| Trial ID: | L1194 |
| Source ID: | NCT02033798
|
| Associated Drug: |
Tamsulosin
|
| Title: |
The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Failure|Prostatic Hyperplasia
|
| Interventions: |
DRUG: Tamsulosin
|
| Outcome Measures: |
Primary: Maximal flow rate, This parameter can be obtained from urodynamic study., 6 months|Maximal detrusor pressure, This parameter can be obtained from urodynamic study., 6 months|Bladder outlet obstruction index, This parameter can be obtained from urodynamic study., 6 months|schäfer grade, This parameter can be obtained from urodynamic study., 6 months|Compliance, This parameter can be obtained from urodynamic study., 6 months | Secondary: Estimated glomerular filtration rate, 6 months|Urinary protein to creatinine ratio, 6 months | Other: International prostate symptom score, 6 months
|
| Sponsor/Collaborators: |
Sponsor: The Catholic University of Korea
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
34
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-02
|
| Completion Date: |
2016-06
|
| Results First Posted: |
|
| Last Update Posted: |
2014-01-17
|
| Locations: |
St. Vincent's Hospital, Suwon, Gyeonggi-do, 442-723, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02033798
|
